Redsense Medical AB
The answer first
Does Redsense Medical beat the market?
No, Redsense Medical has not beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 19% of Nordic stocks
- Quality37
- Value45
- Trend22
No. 133 of 195 in healthcare
Max for seven days
Follow Redsense Medical with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 19 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about Redsense Medical
Your first answer is free, no account needed.
Do you own Redsense Medical, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with Redsense Medical and a few more. Free, no card.
Super Stock+46.4%In short
- Redsense Medical has fallen 17.6% over the past year, including dividends.
- Overall, Redsense Medical ranks better than 19% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 89.4%. The price is 93.3% below its peak now.
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 19% of Nordic stocks.
No. 133 of 195 in healthcare
Medium An average company: the accounts are neither especially strong nor weak.
No. 151 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.00
- Asset turnoverSales divided by everything the company owns0.68
- Return on equityProfit divided by equity−1.8%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Medium Fair price: about the same as a typical Nordic stock.
No. 56 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity1.6
- P/SPrice divided by sales2.1
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
Low Headwind in the share price: it has done worse than most over the last year.
No. 119 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+1.4%
- 6 months−6.6%
- 9 months−1.7%
- 12 months−17.6%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
About Redsense Medical
Redsense Medical AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 4 employees.
Redsense Medical AB (publ) provides an alarm in the event of blood leakage to monitor hemodialysis treatments in Europe, Canada, and Australia. It offers alarm units, such as Redsense, an alarm system for monitoring the blood access during hemodialysis; sensor patches to monitor venous needle or catheter access; and Redsense clamps to automatically stop the blood flow. The company was founded in 2000 and is headquartered in Halmstad, Sweden.


See the full analysis of Redsense Medical.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card